AKT1 and B-cell chronic lymphocytic leukemia: Deguelin downregulates AKT and several downstream targets along the AKT/NFκB pathway that are important for CLL cell survival, like p-65 NFκB subunit, GSK3β, c-Myc, cIAP1/2, XIAP or survivin.